The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Vokes, Everett E.
Item TypeName
Concept Vascular Endothelial Growth Factor Receptor-2
Concept Receptors, Vascular Endothelial Growth Factor
Academic Article A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer.
Academic Article Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia.
Academic Article Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.
Academic Article Role of protein kinase C ß and vascular endothelial growth factor receptor in malignant pleural mesothelioma: Therapeutic implications and the usefulness of Caenorhabditis elegans model organism.
Academic Article Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study.
Academic Article Phase II study of Cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (National Cancer Institute #7097).
Academic Article Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.
Academic Article A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer.
Search Criteria
  • Receptors Vascular Endothelial Growth Factor